secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0000917520-26-000019
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences amends $150M A/R facility, extends termination to April 2029
--------------------------------------------------------------------------------

- Scheduled termination date of $150M accounts receivable securitization facility extended to April 10, 2029.
- Amends representations, covenants, and concentration limits under the Receivables Financing Agreement.
- Also amends Purchase and Sale Agreement with similar covenant changes; PNC Bank remains administrative agent.
- The Bank of Nova Scotia remains a committed lender and group agent under the facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752026000019/0000917520-26-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752026000019/iart-20260410.htm
  HTML page:      https://secwatch.observer/filing/0000917520-26-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer